Evaluation of the effect of duration on dialysis on echocardiographic parameters: A preliminary study

Ellouali, Fédoua; Berkchi, F.; Elhoussni, S.; Bayahia, R.; Benamar, L.; Abouqal, Rédouane; Cherti, Mohammed

doi:10.4103/1319-2442.148748

Cited by 6 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Vascular calcification was determined with a CT value of vessel of 130 or higher by CT scan [13]. All subjects underwent echocardiography on a Hewlett-Packard Sonos 100 device equipped with a 2.25-MHz probe to verify the presence of cardiac valvular calcification, if ≥1 mm strong echo occurred in aortic and mitral, tricuspid leaf, or disc ring as assessed by Doppler echocardiography [14]. …”

Section: Methodsmentioning

confidence: 99%

Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients

et al. 2019

View full text Add to dashboard Cite

Background: Renal osteodystrophy has caused increased risk of fragility fracture in end-stage renal disease (ESRD) patients. However, risk factors and outcome of ESRD patients with fragility fracture remain uncharacterized. We aimed to assess these parameters in ESRD patients. Summary: This retrospective case-control study analyzed 354 ESRD patients (initial fragility fracture [FF] group, n = 59; control group, n = 295). Pre-dialysis blood hemoglobin, serum albumin, lipid, calcium, phosphorus, alkaline phosphatase (ALP), and intact parathyroid hormone (iPTH) were collected. All procedures performed involving human participants were in accordance with the ethical standards of the institutional committee of The First Affiliated Hospital of Chongqing Medical University (IRB approval number 216-82), and informed consent was obtained from all participants. There were higher prevalence rates of primary hypertension and diabetes, higher serum ALP, corrected calcium, and lower serum total cholesterol, low-density lipoprotein, lipoprotein-α, and iPTH in the FF group. Fractures were more likely to occur in the higher level of corrected calcium as well as in the lower iPTH group. High corrected calcium (p = 0.010, OR = 11.308, 95% CI: 1.770–72.242) and serum ALP (p = 0.000, OR = 1.007, 95% CI: 1.004–1.011) were independent risk factors of fragility fracture. The incidence of all-cause mortality and cardiovascular (CV) events in ESRD patients with fragility fracture was higher than in those without fracture. Key Messages: Patients with hypertension, diabetes, excessive suppression of PTH, and poor nutritional status are more prone to fractures. Serum corrected calcium and ALP were independent risk factors of fragility fracture. Patients with initial fragility fracture had more CV events and higher mortality.

show abstract

Section: Methodsmentioning

confidence: 99%

Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Dans notre étude, elle est de 15%. Cette prévalence est similaire à celles de Ezziani et al [5], et Ellouali et al [6] au Maroc qui ont rapporté respectivement des prévalences de 14% et 22,6% dans leurs études. Par contre elle est plus faible par rapport à celle rapportée par Mihailescue et al en Roumanie qui est de 57 > % [7].…”

Section: Discussionunclassified

Calcifications valvulaires chez l’hémodialysé au Maroc

Sa¹,

Noto-Kadou-Kaza²,

Lm³

et al. 2016

Pan Afr Med J

View full text Add to dashboard Cite

IntroductionLes calcifications valvulaires constituent une des complications cardiovasculaires majeures de l'hémodialysé de par sa prévalence et son caractère prédictif de morbidité et de mortalité. De nombreux facteurs de risque sont à l'origine de ces calcifications. Le but de notre étude est d’évaluer à la fois la prévalence des calcifications valvulaires chez nos patients hémodialysés ainsi que leurs facteurs de risque.MéthodesIl s'agissait d'une étude transversale monocentrique, descriptive et analytique, ayant inclus 111 patients adultes hémodialysés depuis plus de 6 mois au centre d'hémodialyse du CHU Ibn Rochd de Casablanca et qui ont eu à bénéficier d'une ETT durant l'année 2013.RésultatsL’âge moyen de nos patients était de 44 ± 14 ans. L'ancienneté moyenne en hémodialyse était de 146 ± 80 mois. La pression artérielle moyenne était de 123 ± 23 mmHg pour la systolique et de 72 ± 13 mmHg pour la diastolique, la PTHi moyenne de 529±460 pg/ml, la calcémie moyenne de 86±10 mg/l et la phosphatémie moyenne de 40±15 mg/l. La CRP moyenne était de 11±19,8 mg/L. Sur le plan thérapeutique, 96% des patients étaient sous carbonate de calcium, 11% sous 25 OH vitamine D, 55,5% sous 1 hydroxy-vitamine D3. La prévalence des calcifications valvulaires était de 15% avec une localisation valvulaire aortique dans 41,2% et valvulaire mitrale dans 41,2%. En analyse univariée, seule la durée d'hémodialyse semble être associée à la survenue des calcifications avec p = 0,09 proche du seuil de significativité.ConclusionLa prévalence des calcifications valvulaires chez nos patients hémodialysés reste élevée même si elle parait relativement moindre comparée aux données de la littérature. Aucun facteur de risque connu n'est apparu significativement associé à ces calcifications.

show abstract

“…All subjects underwent echocardiography with Philips IE33 echocardiograph equipped with a S5-1 PureWave array probe (frequency 1.7/3.3MHz) to veri ed the presence of CVC. CVC was de ned as bright echoes of more than 1 mm on one or more cusps of the aortic valve or mitral valve or mitral annulus [6].…”

Section: Echocardiographymentioning

confidence: 99%

Prognosis and risk factors of cardiac valve calcification in Chinese end-stage renal disease patients

Xiong¹,

Liang²,

Du³

2020

Preprint

View full text Add to dashboard Cite

Background Cardiac valve calcification (CVC) was an important risk factor for cardiovascular complication. But the prevalence, clinical features and risk factors for CVC in ESRD patients were not fully clear at present. In this study, we explored the possible risk factors and clinical characteristics of CVC happened in Chinese ESRD patients. Methods We conducted a retrospective case-control study on 433 cases of ESRD patients who received maintenance dialysis (MHD) for at least 3 months in the First Affiliated Hospital of Chongqing Medical University from October 2014 to December 2015. 93 patients were confirmed to happen cardiac valve calcification (CVC) by echocardiography, and 200 patients without CVC in the same period as control, matched with age and gender. The demographic data, clinical characteristics, and laboratory parameters of the two groups were analyzed. Results Of 433 cases of ESRD patients, the average annual incidence of CVC was 30.3%. The most common calcification was in aortic valve, followed by mitral valve. Dialysis age (P = 0.006, OR = 2.25), serum calcium (P = 0.046, OR = 2.04), diabetes (P = 0.037, OR = 1.81), and pulse pressure ( P < 0.001, OR = 3.22) were the risk factors of CVC, but serum albumin ( P = 0.047, OR = 0.54) was a protective factor for CVC. The ESRD patients with CVC were also more likely to suffer from arrhythmia, heart failure and coronary heart disease (CHD), and the all-cause mortality also increased significantly. Conclusions High prevalence of CVC happened in Chinese ESRD patients, which was a risk signal for severe atherosclerosis, more morbidity and mortality of cardiovascular events in ESRD patients. Dialysis age, serum calcium, diabetes, and pulse pressure were the independent risk factors of CVC in ESRD patients, while serum albumin was a protective factor.

show abstract

Evaluation of the effect of duration on dialysis on echocardiographic parameters: A preliminary study

Cited by 6 publications

References 0 publications

Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients

Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients

Calcifications valvulaires chez l’hémodialysé au Maroc

Prognosis and risk factors of cardiac valve calcification in Chinese end-stage renal disease patients

Contact Info

Product

Resources

About